Market Cap 419.74M
Revenue (ttm) 1.49B
Net Income (ttm) 160.20M
EPS (ttm) N/A
PE Ratio 6.48
Forward PE 8.36
Profit Margin 10.79%
Debt to Equity Ratio 0.28
Volume 747,533
Avg Vol 498,282
Day's Range N/A - N/A
Shares Out 48.75M
Stochastic %K 11%
Beta 1.01
Analysts Hold
Price Target $6.75

Company Profile

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 801 345 1000
Fax: 800 487 8000
Address:
75 West Center Street, Provo, United States
phatsuit
phatsuit Feb. 17 at 4:20 PM
$NUS Just shorted this garbage.
0 · Reply
d_risk
d_risk Feb. 16 at 12:39 AM
$NUS - Nu Skin Enterprises Inc - 10K - Updated Risk Factors NUS’s 2026 10-K risk factors materially expand around China-specific regulatory and operational threats, global direct selling and MLM scrutiny (including FTC and social/media platform risks), granular international and macro risks, evolving sales force/compensation and worker-classification rules, cyber/data/AI exposure, and new sustainability and EU battery compliance obligations, replacing prior high-level summaries with detailed, market- and regulation-specific disclosures. #DirectSelling #ChinaRegulatoryRisks #MLMScrutiny #Cybersecurity #SustainabilityCompliance 🟢 Added 🟠 Removed https://d-risk.ai/NUS/10-K/2026-02-13
0 · Reply
shnitzerbittle
shnitzerbittle Feb. 13 at 6:49 PM
$NUS took a loss here
0 · Reply
ZacksResearch
ZacksResearch Feb. 13 at 3:08 PM
$NUS just gave bulls a reality check ⚠️ Fourth-quarter earnings and sales missed estimates, with revenues down 16.9% Y/Y and broad declines across key global regions. That’s not a one-off hiccup — that’s widespread pressure. Is this a turnaround setup… or a falling knife? See the full breakdown before making your move 👉 https://www.zacks.com/stock/news/2869033/nu-skin-enterprises-q4-earnings-lag-estimates-revenues-down-yy?cid=sm-stocktwits-2-2869033-teaser-33482&ADID=SYND_STOCKTWITS_TWEET_2_2869033_TEASER_33482
0 · Reply
newsfile_corp
newsfile_corp Feb. 13 at 2:45 PM
https://nfne.ws/283830 $NUS @reportablenews #NYSE #Investing
0 · Reply
ZacksResearch
ZacksResearch Feb. 13 at 2:08 PM
$NUS earnings miss — what’s causing the drop? 📉 Nu Skin posted Q4 EPS of 29 cents, missing the Zacks Consensus Estimate of 30 cents, with a 16.9% revenue decline year over year. Customer base and sales leaders also saw significant drops. Understand the risks here 👉 https://www.zacks.com/stock/news/2869033/nu-skin-enterprises-q4-earnings-lag-estimates-revenues-down-yy?cid=sm-stocktwits-2-2869033-body-33480&ADID=SYND_STOCKTWITS_TWEET_2_2869033_BODY_33480
0 · Reply
fer69
fer69 Feb. 13 at 12:35 PM
$NUS loading truck at opening.. will increase this from 2% of portfolio to 4%
0 · Reply
shnitzerbittle
shnitzerbittle Feb. 12 at 11:40 PM
$NUS Looks like forward PE is still higher than trailing. Not good.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 12 at 9:29 PM
$NUS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.30 up 141.10% YoY • Reported revenue of $370.32M down -16.89% YoY • Nu Skin anticipates full-year 2026 revenue of $1.35B to $1.5B, with an approximate 1% foreign currency headwind. Nu Skin projects Q1 2026 revenue of $320 to $340M.
0 · Reply
fer69
fer69 Feb. 12 at 7:45 PM
$NUS also not hedging for a downside here for ER this time … rotation to value is consolidating and in my opinion this still undervalued.. even if ER doesn’t meat expectations I doubt it will drop a lot .. finally we seeing money out of tech going to other sectors .. if ER is better than estimates we could see $15 soon
0 · Reply
Latest News on NUS
Nu Skin Still Has Long-Term Turnaround Potential

Feb 19, 2026, 8:55 AM EST - 10 hours ago

Nu Skin Still Has Long-Term Turnaround Potential


Nu Skin Enterprises Announces Quarterly Dividend

Feb 12, 2026, 4:05 PM EST - 7 days ago

Nu Skin Enterprises Announces Quarterly Dividend


5 Undervalued Safe-Haven Stocks with Strong Dividends

Jan 21, 2026, 2:31 PM EST - 4 weeks ago

5 Undervalued Safe-Haven Stocks with Strong Dividends

CCU CRESY CVGW WMK


Nu Skin Releases 2024 Social Impact and Sustainability Report

Dec 30, 2025, 6:01 PM EST - 7 weeks ago

Nu Skin Releases 2024 Social Impact and Sustainability Report


Nu Skin Enterprises Reports Third Quarter Earnings

Nov 6, 2025, 4:06 PM EST - 3 months ago

Nu Skin Enterprises Reports Third Quarter Earnings


Nu Skin Enterprises Appoints James Winett to Board of Directors

Jun 2, 2025, 12:19 PM EDT - 9 months ago

Nu Skin Enterprises Appoints James Winett to Board of Directors


Nu Skin Enterprises, Inc. (NUS) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:10 PM EDT - 10 months ago

Nu Skin Enterprises, Inc. (NUS) Q1 2025 Earnings Call Transcript


Nu Skin Enterprises Reports Third Quarter Results

Nov 7, 2024, 4:06 PM EST - 1 year ago

Nu Skin Enterprises Reports Third Quarter Results


Nu Skin: Betting On A Potential Comeback

Oct 21, 2024, 1:31 AM EDT - 1 year ago

Nu Skin: Betting On A Potential Comeback


Nu Skin Enterprises Reports Second Quarter Results

Aug 8, 2024, 4:06 PM EDT - 1 year ago

Nu Skin Enterprises Reports Second Quarter Results


phatsuit
phatsuit Feb. 17 at 4:20 PM
$NUS Just shorted this garbage.
0 · Reply
d_risk
d_risk Feb. 16 at 12:39 AM
$NUS - Nu Skin Enterprises Inc - 10K - Updated Risk Factors NUS’s 2026 10-K risk factors materially expand around China-specific regulatory and operational threats, global direct selling and MLM scrutiny (including FTC and social/media platform risks), granular international and macro risks, evolving sales force/compensation and worker-classification rules, cyber/data/AI exposure, and new sustainability and EU battery compliance obligations, replacing prior high-level summaries with detailed, market- and regulation-specific disclosures. #DirectSelling #ChinaRegulatoryRisks #MLMScrutiny #Cybersecurity #SustainabilityCompliance 🟢 Added 🟠 Removed https://d-risk.ai/NUS/10-K/2026-02-13
0 · Reply
shnitzerbittle
shnitzerbittle Feb. 13 at 6:49 PM
$NUS took a loss here
0 · Reply
ZacksResearch
ZacksResearch Feb. 13 at 3:08 PM
$NUS just gave bulls a reality check ⚠️ Fourth-quarter earnings and sales missed estimates, with revenues down 16.9% Y/Y and broad declines across key global regions. That’s not a one-off hiccup — that’s widespread pressure. Is this a turnaround setup… or a falling knife? See the full breakdown before making your move 👉 https://www.zacks.com/stock/news/2869033/nu-skin-enterprises-q4-earnings-lag-estimates-revenues-down-yy?cid=sm-stocktwits-2-2869033-teaser-33482&ADID=SYND_STOCKTWITS_TWEET_2_2869033_TEASER_33482
0 · Reply
newsfile_corp
newsfile_corp Feb. 13 at 2:45 PM
https://nfne.ws/283830 $NUS @reportablenews #NYSE #Investing
0 · Reply
ZacksResearch
ZacksResearch Feb. 13 at 2:08 PM
$NUS earnings miss — what’s causing the drop? 📉 Nu Skin posted Q4 EPS of 29 cents, missing the Zacks Consensus Estimate of 30 cents, with a 16.9% revenue decline year over year. Customer base and sales leaders also saw significant drops. Understand the risks here 👉 https://www.zacks.com/stock/news/2869033/nu-skin-enterprises-q4-earnings-lag-estimates-revenues-down-yy?cid=sm-stocktwits-2-2869033-body-33480&ADID=SYND_STOCKTWITS_TWEET_2_2869033_BODY_33480
0 · Reply
fer69
fer69 Feb. 13 at 12:35 PM
$NUS loading truck at opening.. will increase this from 2% of portfolio to 4%
0 · Reply
shnitzerbittle
shnitzerbittle Feb. 12 at 11:40 PM
$NUS Looks like forward PE is still higher than trailing. Not good.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 12 at 9:29 PM
$NUS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.30 up 141.10% YoY • Reported revenue of $370.32M down -16.89% YoY • Nu Skin anticipates full-year 2026 revenue of $1.35B to $1.5B, with an approximate 1% foreign currency headwind. Nu Skin projects Q1 2026 revenue of $320 to $340M.
0 · Reply
fer69
fer69 Feb. 12 at 7:45 PM
$NUS also not hedging for a downside here for ER this time … rotation to value is consolidating and in my opinion this still undervalued.. even if ER doesn’t meat expectations I doubt it will drop a lot .. finally we seeing money out of tech going to other sectors .. if ER is better than estimates we could see $15 soon
0 · Reply
ZacksResearch
ZacksResearch Feb. 11 at 4:13 PM
$NUS heading into Q4 with pressure building… but not all is bearish. ⚠️ Management is guiding Q4 revenues down 10–18% due to FX and competitive headwinds, yet margin gains and strength in Latin America are offering some cushion. That’s a mixed setup — top-line stress vs. operational resilience. Is this a reset moment or a warning sign? Find out what’s really in the offing 👉 https://www.zacks.com/stock/news/2854567/nu-skin-gears-up-to-report-q4-earnings-whats-in-the-offing?cid=sm-stocktwits-2-2854567-teaser-33053&ADID=SYND_STOCKTWITS_TWEET_2_2854567_TEASER_33053
0 · Reply
LatanyaLilly632
LatanyaLilly632 Feb. 11 at 3:45 PM
$NUS Nu Skin Enterprises; multi-level marketing (MLM) beauty and wellness; faces regulatory scrutiny, high churn, and competition; China exposure.
0 · Reply
ZacksResearch
ZacksResearch Feb. 11 at 3:13 PM
$NUS earnings set to drop — what’s driving the decline? 📉 Nu Skin is facing a tough macro environment with a projected 14.1% revenue drop and 21.1% earnings decline from the year-ago quarter. Increased competition in social commerce and FX headwinds are adding pressure. Full earnings preview here 👉 https://www.zacks.com/stock/news/2854567/nu-skin-gears-up-to-report-q4-earnings-whats-in-the-offing?cid=sm-stocktwits-2-2854567-body-33054&ADID=SYND_STOCKTWITS_TWEET_2_2854567_BODY_33054
0 · Reply
Estimize
Estimize Feb. 9 at 2:03 PM
Wall St is expecting 0.30 EPS for $NUS Q4 [Reporting 02/12 AMC] http://www.estimize.com/intro/nus?chart=historical&metric_name=eps&utm_cont
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 24 at 10:57 PM
$NUS Current Stock Price: $11.05 Contracts to trade: $10 NUS Feb 20 2026 Call Entry: $0.85 Exit: $1.17 ROI: 38% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
newsfile_corp
newsfile_corp Jan. 14 at 9:42 PM
https://nfne.ws/280426 $NUS @reportablenews #NASDAQ #Investing
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 10 at 3:10 PM
$NUS Share Price: $10.15 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $1.15 – $1.42 Target Zone: $1.93 – $2.36 Potential Upside: 59% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Investor6
Investor6 Dec. 7 at 5:21 PM
The most common & classic metrics can be tricky sometimes: For example, low P/E, P/BV, P/Sales doesn't include a high Enterprise Value. Below is a list with U.S. stocks that have low P/E below 5, P/BV below 1, Price/Sales below 1, but also EV/Sales below 1. The list of such undervaluation is short, of course: $NUS The stock price has appreciated YTD. $WW Very low P/E, but with some considerable debt. $WNC Dropped YTD but lately recovers. $IMMR Another one of this list that dropped but lately strongly recovers. GTEC P/E below 2, Negative Enterprise Value. Dropped too, shows signs of recovery lately.
0 · Reply
Investor6
Investor6 Nov. 12 at 11:37 AM
List of U.S. small caps with P/S<1, P/BV<1, and the lowest P/E, according to FinViz. $SDOT had two stock offerings in 2025, $NUS has doubled, $TLF announced losses in Q3, GTEC with very positive Q3 results trades at a P/E of 2, $OPHC announces Q3 results tomorrow.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 12 at 2:33 AM
$NUS Share Price: $9.56 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $1.06 – $1.31 Target Zone: $1.97 – $2.41 Potential Upside: 75% ROI Time to Expiration: 218 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
newsfile_corp
newsfile_corp Nov. 7 at 1:46 PM
https://nfne.ws/273607 $NUS @reportablenews #QuarterlyResults #NYSE #Investing
0 · Reply
ZacksResearch
ZacksResearch Nov. 5 at 11:30 AM
Earnings watch: Can $NUS turn things around this quarter? 📊 Nu Skin is set to report its Q3 numbers, and all eyes are on what the results reveal about the company’s near-term momentum. Full preview and expectations here 👉 https://www.zacks.com/stock/news/2785394/nu-skin-to-report-q3-earnings-whats-in-the-cards-for-nus-stock?cid=sm-stocktwits-2-2785394-teaser-19478&ADID=SYND_STOCKTWITS_TWEET_2_2785394_TEASER_19478
0 · Reply